Editor-in-Chief: Daniel Scherman
Submission to first decision: 72 days

Rare Disease and Orphan Drugs Journal

Articles

Most Recent | Most Viewed | Most Downloaded

The complexity of funding rare disease research: an IRDiRC assessment of the landscape

Open Access Review DOI: 10.20517/rdodj.2024.18 8 Sep 2024
Views: Downloads:
Download PDF

Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells

Open Access Review DOI: 10.20517/rdodj.2024.16 1 Sep 2024
Views: Downloads:
Download PDF

Exploratory survey study on adjunctive use of medical cannabis for Gaucher disease

Open Access Original Article DOI: 10.20517/rdodj.2024.17 22 Aug 2024
Views: Downloads:
Download PDF

Patient organizations: advocating for timely newborn screening & improved quality of life

Open Access Perspective DOI: 10.20517/rdodj.2024.11 14 Aug 2024
Views: Downloads:
Download PDF

Framing the European Rare Diseases field through a structured movement of patient organisations

Open Access Perspective DOI: 10.20517/rdodj.2023.58 30 Jul 2024
Views: Downloads:
Download PDF

The importance of psychological support for parents and caregivers of children with a rare disease at diagnosis

Open Access Review DOI: 10.20517/rdodj.2022.04 7 Apr 2022
Views: Downloads:
Download PDF

Connecting academia and industry for innovative drug repurposing in rare diseases: it is worth a try

Open Access Perspective DOI: 10.20517/rdodj.2023.06 9 Apr 2023
Views: Downloads:
Download PDF

Sustainable approaches for drug repurposing in rare diseases: recommendations from the IRDiRC Task Force

Open Access Perspective DOI: 10.20517/rdodj.2023.04 24 Apr 2023
Views: Downloads:
Download PDF

Topic: Advances in Neurofibromatosis - The Future is Bright

Submission Deadline: 28 Feb 2025

Published articles: 0

Submission Deadline: 15 Jan 2025

Published articles: 0

During the interview, Dr. Hagerman elaborated on the key points of her article, current research, and prospects within the field of Fragile X Syndrome, and offered suggestions for the future development of the journal.
During the interview, Dr. Politei talked about the highlight of this article, his current research, prospects in the field of Fabry diseases, suggestions for the future development of the journal.
Rare Disease and Orphan Drugs Journal is delighted to announce support for the 2024 Global Rare Disease Research Symposium

Topic: Advances in Neurofibromatosis - The Future is Bright

Submission Deadline: 28 Feb 2025

Published articles: 0

Submission Deadline: 15 Jan 2025

Published articles: 0

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/